In-house product
Mebhydrolin Napadisylate is indicated in-
Allergic disease or symptoms such as urticaria
Pruritus of various origin
Eczema
Itching
Drug rash
Insect bites
Allergic conjunctivitis
Dermatitis of nutritional origin
Hay fever,
Vasomotor rhinitis
Allergic asthma.
The effects of atropine and tricyclic anti-depressants may be enhanced by Mebhydrolin. It may mask the warning symptoms of damage caused by ototoxic drugs.
Hypersensitivity to any of the ingredients of Mebhydrolin tablet or to mebhydrolin
Prostatic hypertrophy, narrow-angle glaucoma.
First trimester of pregnancy.
Lassitude, dizziness, hypotension, muscular weakness, nausea, vomiting, diarrhoea or constipation, epigastric pain, headache, blurred vision, tinnitus, depression, nightmares, anorexia, dryness of the mouth, tightness of the chest, tingling, sedation, drowsiness etc. may occur.
Adults and children over 10 years: 2-6 tablets dailyChildren-
5-10 years: 2-4 tablets daily
2-5 years: 1-3 tablets daily
Up to 2 years: 1-2 tablets daily
Treatment should be given in several single doses daily. Mebhydrolin may be swallowed during or shortly after meals. For children, the tablet may be crushed and mixed with food.
n/a
Safety in pregnancy and lactation has not been established.
The substance may cause drowsiness, if affected, driving or operating machinery & alcoholic drinks should be avoided.
n/a
Sedating Anti-histamine
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
n/a
Mebhydrolin diminishes or abolishes the main actions of histamine in the body by blocking of histamine receptors.
n/a
Login or Registerto submit your questions to seller
No none asked to seller yet